Catherine Shore-Lorenti (Cat Shore-Lorenti)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Combination Therapy

Postmenopausal Women

Dna Methylation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann, Shane White, Belinda Yeo, Prudence A Francis, Cecilia L H Xu, Olivia Coleman, Catherine Shore-Lorenti, Peter R Ebeling, Jeffrey D Zajac, Ego Seeman, Mathis Grossmann
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Wei Zhou, Joel Ås, Catherine Shore-Lorenti, Hanh H Nguyen, Denise M van de Laarschot, Shoshana Sztal-Mazer, Vivian Grill, Christian M Girgis, Bruno H Ch Stricker, Bram C J van der Eerden, Rajesh V Thakker, Natasha M Appelman-Dijkstra, Mia Wadelius, Roderick Clifton-Bligh, Pär Hallberg, Annemieke J M H Verkerk, Jeroen G J van Rooij, Peter R Ebeling, M Carola Zillikens
Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fractures. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2024)